Liquid Formulation Treanda (bendamustine Hci) Injection Trademark Details

Liquid Formulation Treanda (Bendamustine Hci) Injection was registered on Tuesday, March 3, 2015 and is currently owned by Cephalon, Inc. under the registration number 4696840 . This mark is alive with a status of Registered. The last case file activity for this mark occured 9 years ago on Tuesday, March 3, 2015, according to the United State Patent & Trademark Office
Word Mark Liquid Formulation Treanda (Bendamustine Hci) Injection
Status Alive Registered 700 — Registered

Current Owner

Cephalon, Inc. of Salt Lake City, UT

View all trademarks for Cephalon, Inc.
Other Trademarks for Cephalon, Inc.
Serial Number 86088292
Registration Number 4696840
Status Date Tuesday, March 3, 2015
Filing Date Tuesday, March 3, 2015
Registration Date Tuesday, March 3, 2015

Correspondent

HERSCHEL PEREL
TEVA PHARMACEUTICALS USA
425 PRIVET RD
HORSHAM, PA 19044-1220

Case File Statements

Indication of Colors The color(s) Purple, green and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text "Liquid Formulation", "Bendamustine Hci", "Injection"
Description of Mark The mark consists of the purple words "LIQUID FORMULATION" written on top of the black word "TREANDA" and the black words "BENDAMUSTINE HCI" written in black brackets and the black word "INJECTION" written outside the brackts with design of two green and purple eye brows on the left side of the mark.
Goods & Services Pamphlets and brochures containing information regarding the treatment of cancer

Classifications

International Class Codes
016 — Class 16 includes mainly paper, goods made from that material and office requisites.
U.S. Class Codes 002, 005, 022, 023, 029, 037, 038, 050
Status 6 — Active
Status Date Friday, October 18, 2013
First Use Anywhere Monday, November 17, 2014
First Use In Commerce Monday, November 17, 2014
Primary Code 016

You must be signed in to print.

Once signed in, look for the PDF button.